Research:
Crohn's Disease Research Inc: Mycobacterium avium ss. paratuberculosis (MAP) and it's role as a possible causative or triggering agent in the development of Crohn's Disease.

Trials:
Crohn's Disease Research Inc: Rifabutin and Macrolide Antibiotic Therapy (RMAT) study to determine the effectiveness of this treatment in inducing remission in MAP positive subjects.

Santarus: AZA-DR trial

Genetics Inst. Labs: IL-11 

Procter&Gamble: Mesalamine for Ulcerative Colitis

Crohn's Disease Research Inc: Probiotics for Crohn's
 
 

 The information contained in this site is intended for information purposes only and is not intended as a means of diagnosing or treating disease. Please consult your doctor before starting any treatment.